Amyotrophic Lateral Sclerosis
FY23 Programmatic Panel:
Lyle Ostrow, M.D., Ph.D. (Chair)
Lewis Katz School of Medicine at Temple University
Katja Brose, Ph.D.
Chan Zuckerberg Initiative
Kuldip Dave, Ph.D.
ALS Association
Christina Fournier, M.D., M.Sc.
Emory University
Maj. Timothy Fullam, M.D., U.S. Air Force
Brooke Army Medical Center
Moon Han, Ph.D., M.P.H., M.Sc.
Centers for Disease Control and Prevention
Matt Harms, M.D.
Columbia University
Terry Heiman-Patterson, M.D.
Lewis Katz School of Medicine at Temple University
Joseph Lewcock, Ph.D.
Denali Therapeutics
Michael Robinson, M.D.
Healey Platform Trial Patient Advisor
Ghazaleh Sadri-Vakili, Ph.D., M.S.
Harvard Medical School
Nadia Sethi, D.D.S.
I AM ALS
David Taylor, Ph.D.
ALS Society of Canada
Carol Taylor-Burds, Ph.D.
National Institute of Neurological Disorders and Stroke, National Institutes of Health
Last updated Friday, December 1, 2023